Format

Send to

Choose Destination
Immunol Allergy Clin North Am. 2007 Aug;27(3):457-75.

Cardiovascular manifestations of hypereosinophilic syndromes.

Author information

1
Allergy and Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Room B1-05, Bldg. 4, Bethesda, MD 20892, USA. ogbogup@niaid.nih.gov

Abstract

The hypereosinophilic syndromes (HESs) are characterized by persistent marked eosinophilia (>1500 eosinophils/mm(3)), the absence of a primary cause of eosinophilia (such as parasitic or allergic disease), and evidence of eosinophil-mediated end organ damage. Cardiovascular complications of HES are a major source of morbidity and mortality in these disorders. The most characteristic cardiovascular abnormality in HES is endomyocardial fibrosis. Patients who have an HES also may develop thrombosis, particularly in the cardiac ventricles, but also occasionally in deep veins. Because of the rarity of these disorders, specific guidelines for the management of the cardiac and thrombotic complications of HES are lacking. This article reviews the diagnosis and management of the cardiovascular manifestations of HES.

PMID:
17868859
PMCID:
PMC2048688
DOI:
10.1016/j.iac.2007.07.001
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center